VICENTE DAMIÁN ESCUDERO VILAPLANA-rekin lankidetzan egindako argitalpenak (13)

2023

  1. Anti-interleukin-17 therapies for moderate/severe psoriasis in clinical practice: effectiveness, safety and association with clinical patient factors

    European Journal of Hospital Pharmacy

2021

  1. Error detection and cost savings with an image-based workflow management system connected to a computerized prescription order entry program for antineoplastic compounding

    Journal of Patient Safety, Vol. 17, Núm. 8, pp. E1589-E1594

2020

  1. Effect of a Mobile App for the Pharmacotherapeutic Follow-Up of Patients with Cancer on Their Health Outcomes: Quasi-Experimental Study

    JMIR mHealth and uHealth, Vol. 8, Núm. 10

  2. Novel mobile application for direct communication between pharmacists and patients treated with oral antineoplastic agents

    American Journal of Health-System Pharmacy, Vol. 77, Núm. 17, pp. 1393-1402

  3. Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients’ safety

    Health Informatics Journal, Vol. 26, Núm. 3, pp. 1995-2010

2019

  1. Development and Evaluation of a Clinical Decision Support System to Improve Medication Safety

    Applied Clinical Informatics, Vol. 10, Núm. 3, pp. 513-520

  2. Robotic dispensing improves patient safety, inventory management, and staff satisfaction in an outpatient hospital pharmacy

    Journal of Evaluation in Clinical Practice, Vol. 25, Núm. 1, pp. 28-35

2018

  1. Twelve weeks of ombitasvir/paritaprevir/r and dasabuvir without ribavirin is effective and safe in the treatment of patients with HCV genotype 1b infection and compensated cirrhosis: results from a real-world cohort study

    Expert Opinion on Drug Safety, Vol. 17, Núm. 3, pp. 235-241

2017

  1. Improving pharmacotherapy outcomes in patients with hepatitis C virus infection treated with direct-acting antivirals: The GRUviC project

    International Journal of Clinical Practice, Vol. 71, Núm. 8

2016

  1. Guiding pharmacist clinical interviews: A safety tool to support the education of patients treated with oral antineoplastic agents

    Expert Opinion on Drug Safety, Vol. 15, Núm. 4, pp. 427-435

  2. Oral antineoplastic agent interactions with medicinal plants and food: an issue to take into account

    Journal of Cancer Research and Clinical Oncology, Vol. 142, Núm. 11, pp. 2319-2330

  3. Pharmaceutical care program for onco-hematologic outpatients: safety, efficiency and patient satisfaction

    International Journal of Clinical Pharmacy, Vol. 38, Núm. 2, pp. 280-288

2014

  1. Utilización de agentes estimulantes de la eritropoyesis en el tratamiento de la anemia secundaria a enfermedad renal crónica

    Utilización de agentes estimulantes de la eritropoyesis en el tratamiento de la anemia secundaria a enfermedad renal crónica